Los Angeles Lakers star Luka Doncic sheds pounds the natural way without Ozempic
The Los Angeles Lakers' star Luka Doncic has received numerous trolls due to a slightly thinner version of himself during the offseason. Critics are saying that he has lost weight using some medication and not the natural way.
However, during his recent interview, Luka Doncic broke the silence and said something that seemed like a straightaway slap on the face of the critics. He shut the mouths of everyone by saying that his new look was the result of his new diet plan and constant exercise.
His constant determination to work hard and come back fit in the next season has led to his drastic weight loss. This reply came as a shocking surprise for both the fans and critics.
As fans await his thinner version in the next season, Luka Doncic is yet to show some of his best moves.
Luka Doncic breaks silence on losing weight using natural means rather than medications
Luka Doncic has turned the tables by revealing how he managed to lose weight in an old-fashioned way. On Wednesday, the Lakers star joined 'Today' and was interviewed. 'No Ozempic, none of those shots or anything?' asked Craig Malvin, surprising the viewers with such a blatant question. To this, Luka Doncic said something that surprised everyone.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Is this legal? Access all TV channels without a subscription!
Techno Mag
Learn More
Undo
He said that he had been losing weight with a new diet and regular exercise.
He even said that he took an entire month off from basketball just to focus on his physique because this is something he has never done before. Luka Doncic's latest posts have earned him much appreciation from his fans and the media. However, it's tough to shut the mouths of the critics, isn't it?
Los Angeles Lakers' Luka Doncic faced a lot of criticism after major weight loss
As stated earlier, it is difficult to shut everyone, especially the critics.
Luka Doncic's latest posts have also gained much public attention since he has lost tons of pounds within such a short period of time. The hate comments are surreal. Critics never fail to criticize, even if the matter is personal and unrelated to their expertise. However, this could not shake the Lakers star as he continues his journey while making a major comeback in the next season.
'I think I was still a pretty good basketball player back then, no matter what people say.'
Luka Doncic said on 'Today'.
Luka Doncic on offseason transformation
The interview with 'Today' was about Luka Doncic and his major weight loss journey. On asking about how he feels about being trolled to such an extent, he replied, 'I think I was still a pretty good basketball player back then, no matter what people say'. 'I think it is the next step in my career, at the end, I am still 26 and I've got a long way to go, so that was a good step in my career', the Lakers' star added. This indeed is one of his finest achievements in his NBA career because taking a full month break from the game to transform oneself is not for the weak.
Also read:
Luka Doncic's Subtle Jab at the Dallas Mavericks Amid Los Angeles Lakers Resurgence and Contract Talks
FAQs
For which team does Luka Doncic play?
Luka Doncic plays for the Los Angeles Lakers.
Did Luka Doncic go through any medication like Ozempic to lose weight?
No, Luka Doncic didn't go through any medication; it was all natural.
How did Luka Doncic lose weight then?
Luka Doncic had gone through a new diet plan along with regular exercise.
Catch Rani Rampal's inspiring story on Game On, Episode 4. Watch Here!
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
4 hours ago
- Hindustan Times
Doctor shares 10 daily foods that mimic Ozempic and make weight loss easier
Ozempic is not just a celebrity buzzword! It is a prescription drug originally developed to treat type 2 diabetes, now widely talked about for its surprising weight loss effects. This buzz has sparked curiosity about whether there are natural alternatives to Ozempic. The answer is yes! Dr Adrian, a functional medicine doctor and MD specializing in thyroid, PCOS, and gut health, recently shared on Instagram a list of foods that may work in a similar way. These foods can help boost GLP-1, the hormone that curbs unnecessary hunger and helps control appetite, supporting a healthy weight loss. Try these foods to naturally boost GLP-1 levels! (Adobe Stock) What is Ozempic? Ozempic is the brand name for semaglutide, a medication created by Danish drugmaker Novo Nordisk. It belongs to a class of drugs called GLP-1 receptor agonists, meaning it imitates the effects of a hormone your body naturally produces, GLP-1. First approved by the US Food and Drug Administration in 2017 for managing type 2 diabetes, Ozempic comes as a once-weekly injection, usually given in the abdomen, thigh, or upper arm using a prefilled pen. How does GLP-1 support weight loss? GLP-1 is an incretin hormone released in your gut after you eat. Health Shots also got in touch with dietitian Vidhi Chawla to learn more about it. She says, 'It triggers more insulin, curbs glucagon (which raises blood sugar), and slows digestion, all of which help keep blood sugar stable and reduce appetite.' That is why Ozempic is effective for weight loss. Foods to boost GLP-1 Here are 10 foods that may help make weight loss feel easier and quicker with an Ozempic prescription: 1. Avocados Packed with healthy monounsaturated fats and fibre, avocados keep hunger hormones in check. Dr Adrian notes that their slow-digesting fat content supports steady blood sugar, while the fibre helps keep you feeling full for longer. A study published in Nutrients revealed that eating a whole avocado can boost GLP-1 levels, along with reducing cravings and appetite. This food is also rich in potassium, which supports metabolism and slows down digestion. 2. Chia seeds These tiny seeds are a powerhouse of soluble fibre. When soaked, they form a gel in your stomach that slows digestion, much like Ozempic delays gastric emptying (the rate at which food moves from the stomach to the small intestine). Vidhi Chawla adds that chia seeds are also a good plant-based omega-3 source, supporting gut health and reducing inflammation linked to weight gain. 3. Potatoes Often misunderstood, potatoes (especially boiled or baked) are among the most satiating foods that can support weight loss. They provide slow-digesting carbs that keep energy stable. Dr Adrian points out that their resistant starch content feeds beneficial gut bacteria, which may indirectly support weight control. 4. Oats Oats, particularly rolled oats, are rich in beta-glucan, a soluble fibre that triggers fullness hormones. They are a steady energy source that reduces the risk of unwanted hunger. Vidhi recommends starting your day with oatmeal paired with protein, like Greek yogurt, for even better hunger control. According to her, fibre rich foods help reduce your calorie intake by promoting the feeling of fullness. Oats can support weight loss!(Adobe Stock) 5. Eggs and egg whites Eggs are loaded with protein that lowers ghrelin, the "I'm hungry" hormone. Their amino acids also support muscle maintenance during weight loss. Having them at breakfast can help curb appetite for hours, making them a simple yet effective tool in any weight-loss-friendly diet. So, make sure you start your day with a protein and fibre-rich breakfast to support weight loss. 6. Greek Yogurt Thick, creamy, and protein-rich, Greek yogurt is digested slowly, keeping you satisfied for longer. Its probiotic content supports gut health, which is linked to better weight management. Dr Adrian advises choosing unsweetened versions to avoid unnecessary sugar spikes. 7. Lean meat From skinless chicken to turkey, lean meats deliver high-quality protein that boosts metabolism due to the thermic effect of food. This means you burn more calories even when digesting food. Vidhi notes that protein also helps prevent the muscle loss often seen in rapid weight loss, keeping metabolism healthy. 8. Fish Fatty fish like salmon, mackerel, and sardines offer both protein and omega-3 fats. Dr Adrian says this combo reduces inflammation, balances hormones, and suppresses appetite. Eating fish 2–3 times a week can be a game-changer for promoting both satiety and metabolic health. 9. Berries Low in sugar but high in fibre, berries are ideal for controlling blood sugar spikes. Their antioxidants also help reduce inflammation, which can interfere with hunger and satiety signals. Vidhi suggests pairing berries with Greek yogurt for a balanced, filling snack. 10. Leafy greens Spinach, kale, broccoli, and other fibre-rich vegetables are filling yet low in calories. They fill your stomach, stimulate fullness hormones, and deliver vitamins that support overall metabolic function, explains Dr Adrian. One 2022 study published in the International Journal of Preventive Medicine found that eating vegetables before carbohydrates significantly improves glucose and GLP-1 levels in people with type 2 diabetes. What's more? Since they are also high in vitamins, minerals, and antioxidants, they can also help support healthy metabolism and the fat-burning process.
Mint
16 hours ago
- Mint
Biogen Sees Potential in Combining Alzheimer's and Obesity Drugs
(Bloomberg) -- If Novo Nordisk A/S's wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer's disease, Biogen Inc.'s Chief Executive Officer Chris Viehbacher doesn't see it as a roadblock for his company's medication. Rather, he sees it as an opportunity to potentially combine drugs and create a more potent therapy. 'As we look out over the next five years, we're probably going to see a treatment much like any other complex disease,' he said in an interview with Bloomberg News, meaning there will be 'different mechanisms of action that you need.' It's not uncommon for drugmakers to study combinations of treatments when two seem to work for the same condition, in hope of boosting the benefit. Viehbacher said if Novo's study works, Biogen 'might' do trials looking at the two drugs in combination but cautioned the timeline might not make sense given Alzheimer's studies take years to complete. Biogen's looking to the growth of its Alzheimer's drug Leqembi to offset the decline of its multiple sclerosis franchise, which is facing competition from cheaper generic drugs. Biogen's new Alzheimer's drug is already facing competition from Eli Lilly & Co.'s Alzheimer's drug, which was approved in the US last year and has since captured around 30% of the market, according to analysts. Other companies are also circling. Novo is carrying out clinical trials to assess whether the main ingredient in diabetes drug Ozempic and weight-loss shot Wegovy might help people with early Alzheimer's disease. Research suggests that the weight-loss drug could slow Alzheimer's progression by impacting inflammation and vascular health. Results of Novo's late-stage trial are expected later this year. Viehbacher noted that being overweight is a risk factor for Alzheimer's. He cautioned the Novo study 'is a fairly risky proposition,' adding that 'most of the experts we're talking to are not convinced that it will work.' 'It's logical if you have a weight-loss drug that you can see some benefit, but it's actually pretty hard to move the needle on the cognitive side,' Viehbacher added. Alzheimer's drug development has been riddled with failures, even when drugs looked promising in early studies. Leqembi is a partnership between Cambridge, Massachusetts-based Biogen and Japanese drugmaker Eisai Co. Biogen makes the active ingredient for Leqembi in Switzerland. The company then ships it to North Carolina, where it gets made into a product. President Donald Trump recently put a 39% tariff on imports from Switzerland. It's unclear whether this would impact Biogen's drug. Still, Viehbacher said the company has the ability to start producing the substance used to make Leqembi in North Carolina for the US market, while continuing to make it in Switzerland for outside the US. He said the company always intended to use its North Carolina facilities to make Leqembi and the potential move was not a direct response to Trump's tariff threats. Last month, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park. More stories like this are available on
India Today
19 hours ago
- India Today
From Rs 30,000 to Rs 3,000, India's weight-loss game is changing. What's the catch?
India is on the brink of a weight-loss revolution. What has long been a luxury reserved for the ultra-rich is now on the cusp of becoming mainstream. With anti-obesity drugs like semaglutide set to drop in price from a staggering Rs 30,000 to just Rs 3,000 per month, millions of Indians battling weight issues could finally gain access to life-changing pharmaceutical giants gear up to flood the market with affordable generics, 2026 is expected to mark not just the arrival of next-gen weight-loss medication—but the beginning of a nationwide health is this transformation entirely welcome? And are we prepared for what it brings? First let's understand, why now?Globally, GLP 1 drugs like Ozempic and Wegovy have already helped nearly 20 million people lose weight since 2021. But in India? Access has been painfully slow and painfully expensive. Until now. The core ingredient in these blockbuster drugs, semaglutide, is going off patent in 2026 not just in India but in over 80 countries including Canada, China, Brazil, and Saudi that happens, prices are expected to fall hard—by as much as 85 to 90 percent. That means what once cost Rs 20,000 to 30,000 a month could soon be available for as little as Rs 2,500 to Rs 4,000. For the average Indian earning around Rs 17,000 a month, that's a massive shift from completely out of reach to will be a fundamental shift in who gets to access obesity care. We're talking about taking weight-loss drugs from elite clinics in metros and putting them in the hands of everyday Indians. With nearly 33 percent of Indian adults struggling with obesity, this could have a massive public health impact. But with mass access comes a set of new SOUND CAUTION: WILL THIS ACCELERATE MISUSE?While the promise of affordable treatment is exciting, doctors are urging caution.'Undoubtedly the reduction in cost will allow access to a much larger segment of the Indian population, the drugs will not be elite anymore. Whenever prices go down, it always helps our patients. I assume the quality checks will be maintained as generics enter the challenge of course is, that misuse will become easier. Misuse might already be happening, and this could further increase. But overall, I think the benefits outweigh the challenges, I am quite optimistic about this move,' says Dr. Ambrish Mithal, India's leading endocrinologist and author of "The weight-loss revolution."To handle the misuse, countries like Portugal have given only doctors with approved specialities, permits to prescribe these drugs as a way of controlling the misuse. Something that doctors in India are now and when the drugs will become more affordable it will clear impact entire spectrum of more than 200 conditions which are impacted with people living with obesity. The cosmetic use and misuse of label need to be contained because these drugs have compelling data on complications and co morbidity and must be given under expert supervision,' warns Padma Shri Dr Shashank Joshi, who has been at the forefront of diabetes and obesity care in there is a genuine sounding of caution, there is also the flip side to the generic race for weight-loss patents expiring, the doors are wide open for Indian pharma players to jump in and they're wasting no time. Over 10 Indian companies have already filed for clinical trials, mostly for oral versions of semaglutide (no injections necessary).Add to that the competition from Chinese manufacturers, and what you get is a perfect storm of falling prices. Experts predict costs could plunge by up to 70 percent even before 2026, as generic versions hit the shelves and reshape the this isn't just a drug story. The ripple effects across the healthcare ecosystem could be enormous: Insurers may begin covering weight-loss therapies, Hospitals may roll out dedicated obesity programs, Startups are already building subscription-based models that combine medication, coaching, and lifestyle trackingadvertisementIt's not just about shrinking waistlines—it's about reimagining public health.A CLEARER TIMELINE: WHAT TO EXPECT AND WHENHere's how the semaglutide story is expected to play out in India:Late 2025: Branded semaglutide drugs become legally available in India through formal pharma 2026: Patent expiration triggers launch of the first Indian-made generics—both injectable and to late 2026: Prices drop significantly (up to 85 to 90 percent), demand spikes, and mass availability 2027: Generic semaglutide becomes a first line treatment for obesity across urban and semi urban conclusion, what was once a Rs 30,000-a-month treatment is set to drop to Rs 3,000 or less. That's a game-changer—not just for individuals, but for India's public health system.2025 has already seen the early entry of next-gen weight-loss drugs into the Indian market. 2026 will be the year they go if we want this revolution to truly succeed, we need more than cheap drugs. We need education, regulation, and ethical if we're not careful, India could end up facing the same problems the West is already struggling with—from overuse and side effects to social media-fuelled that's not the kind of health transformation anyone wants.- EndsMust Watch
